Published in Clin Infect Dis on March 01, 2010
Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis (2011) 2.22
Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One (2010) 2.15
Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog (2011) 1.87
Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes. J R Soc Interface (2011) 1.40
Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis (2012) 1.39
Dynamics of airborne influenza A viruses indoors and dependence on humidity. PLoS One (2011) 1.19
High humidity leads to loss of infectious influenza virus from simulated coughs. PLoS One (2013) 1.14
Dispersion and exposure to a cough-generated aerosol in a simulated medical examination room. J Occup Environ Hyg (2012) 1.03
Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness. J Occup Environ Hyg (2012) 1.02
Viable influenza A virus in airborne particles from human coughs. J Occup Environ Hyg (2015) 0.99
A comprehensive breath plume model for disease transmission via expiratory aerosols. PLoS One (2012) 0.94
Comparison of five bacteriophages as models for viral aerosol studies. Appl Environ Microbiol (2014) 0.94
Aerosol susceptibility of influenza virus to UV-C light. Appl Environ Microbiol (2012) 0.91
Qualitative real-time schlieren and shadowgraph imaging of human exhaled airflows: an aid to aerosol infection control. PLoS One (2011) 0.90
Progress in respiratory virus vaccine development. Semin Respir Crit Care Med (2011) 0.89
Development of an improved methodology to detect infectious airborne influenza virus using the NIOSH bioaerosol sampler. J Environ Monit (2011) 0.89
Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical procedures. PLoS One (2013) 0.87
Airborne transmission of influenza: implications for control in healthcare and community settings. Clin Infect Dis (2012) 0.86
Comparison of the levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes. J Virol (2013) 0.84
Surveillance of airborne adenovirus and Mycoplasma pneumoniae in a hospital pediatric department. PLoS One (2012) 0.83
Airflow dynamics of coughing in healthy human volunteers by shadowgraph imaging: an aid to aerosol infection control. PLoS One (2012) 0.83
The use of respirators to reduce inhalation of airborne biological agents. J Occup Environ Hyg (2013) 0.82
Influenza virus aerosols in the air and their infectiousness. Adv Virol (2014) 0.81
Validation and application of models to predict facemask influenza contamination in healthcare settings. Risk Anal (2014) 0.80
Establishment and clinical applications of a portable system for capturing influenza viruses released through coughing. PLoS One (2014) 0.80
Association of over-the-counter pharmaceutical sales with influenza-like-illnesses to patient volume in an urgent care setting. PLoS One (2013) 0.79
Clinician Beliefs and Attitudes Regarding Use of Respiratory Protective Devices and Surgical Masks for Influenza. Health Secur (2015) 0.78
Concentration, Size Distribution, and Infectivity of Airborne Particles Carrying Swine Viruses. PLoS One (2015) 0.78
Seasonal Dynamics of the Airborne Bacterial Community and Selected Viruses in a Children's Daycare Center. PLoS One (2016) 0.77
Quantification of Influenza Virus RNA in Aerosols in Patient Rooms. PLoS One (2016) 0.77
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands. Drugs Ther Perspect (2016) 0.77
Criteria for the collection of useful respirator performance data in the workplace. J Occup Environ Hyg (2014) 0.77
Extraction of Aerosol-Deposited Yersinia pestis from Indoor Surfaces To Determine Bacterial Environmental Decay. Appl Environ Microbiol (2016) 0.75
A simple novel device for air sampling by electrokinetic capture. Microbiome (2015) 0.75
Viable influenza A virus in airborne particles expelled during coughs versus exhalations. Influenza Other Respir Viruses (2016) 0.75
Exposure to influenza virus aerosols in the hospital setting: is routine patient care an aerosol generating procedure? J Infect Dis (2014) 0.75
Collection of Viable Aerosolized Influenza Virus and Other Respiratory Viruses in a Student Health Care Center through Water-Based Condensation Growth. mSphere (2017) 0.75
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Stroke. Lancet (2008) 9.51
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust (2003) 4.24
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology (2009) 3.52
Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis (2009) 3.01
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol (2002) 2.79
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke (2008) 2.39
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 2.25
Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol (2002) 2.25
Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One (2010) 2.15
The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit. Med J Aust (2002) 2.13
Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location. J Neurol Sci (2013) 2.11
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
National healthline responses to a stroke scenario: implications for early intervention. Stroke (2007) 2.06
Emergency department workload increase: dependence on primary care? J Emerg Med (2009) 2.04
Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke (2011) 2.03
Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med (2010) 1.97
World Stroke Organization global stroke services guidelines and action plan. Int J Stroke (2014) 1.94
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke (2004) 1.81
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Med J Aust (2007) 1.71
Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology (2012) 1.70
Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology (2013) 1.69
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab (2010) 1.68
The physiological significance of the time-to-maximum (Tmax) parameter in perfusion MRI. Stroke (2010) 1.62
Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust (2003) 1.61
Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke (2003) 1.59
Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol (2009) 1.59
Measurement capability of field portable organic vapor monitoring instruments under different experimental conditions. J Occup Environ Hyg (2009) 1.58
Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci (2009) 1.55
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke (2011) 1.52
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis (2013) 1.52
Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke. J Clin Neurosci (2010) 1.49
Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre Toxicol (2008) 1.49
Association between early returns and frequent ED visits at a rural academic medical center. Am J Emerg Med (2003) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 1.47
Patients with transient ischemic attack or minor stroke should be admitted to hospital: for. Stroke (2006) 1.45
Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol (2011) 1.44
MRI and stroke: why has it taken so long? Lancet (2007) 1.44
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42
Mismatch-based delayed thrombolysis: a meta-analysis. Stroke (2009) 1.41
When to measure lipid profile after stroke? Cerebrovasc Dis (2005) 1.39
Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis (2012) 1.39
Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab (2013) 1.36
A two-stage cyclone using microcentrifuge tubes for personal bioaerosol sampling. J Environ Monit (2006) 1.35
Airborne fungal fragments and allergenicity. Med Mycol (2006) 1.35
Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol (2014) 1.35
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
Carbon nanotube dosimetry: from workplace exposure assessment to inhalation toxicology. Part Fibre Toxicol (2013) 1.33
Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J Biol Chem (2002) 1.29
Violence in the emergency department: a national survey of emergency medicine residents and attending physicians. J Emerg Med (2010) 1.27
Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke (2009) 1.23
How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol (2011) 1.22
Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke (2012) 1.21
Patent foramen ovale and stroke: closure by further randomized trial is required! Stroke (2004) 1.20
The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke (2010) 1.20
Aerosolization of single-walled carbon nanotubes for an inhalation study. Inhal Toxicol (2008) 1.19
Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis (2007) 1.19
Profiling mild steel welding processes to reduce fume emissions and costs in the workplace. Ann Occup Hyg (2014) 1.18
Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Rapid Commun Mass Spectrom (2008) 1.17
Stroke thrombolysis: save a minute, save a day. Stroke (2014) 1.17
Comparison of stainless and mild steel welding fumes in generation of reactive oxygen species. Part Fibre Toxicol (2010) 1.17
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16
High humidity leads to loss of infectious influenza virus from simulated coughs. PLoS One (2013) 1.14
Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke (2009) 1.13
Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J Stroke Cerebrovasc Dis (2012) 1.12
Bioaerosol sampling for the detection of aerosolized influenza virus. Influenza Other Respir Viruses (2007) 1.12
Nanoparticle inhalation alters systemic arteriolar vasoreactivity through sympathetic and cyclooxygenase-mediated pathways. Nanotoxicology (2011) 1.12
Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study. Int J Mol Sci (2012) 1.12
Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol (2002) 1.11
Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting. Infect Control Hosp Epidemiol (2009) 1.10
A comparison of National Emergency Department use by homeless versus non-homeless people in the United States. J Health Care Poor Underserved (2009) 1.09
EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration. Stroke (2010) 1.09
The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci (2002) 1.09
Intracerebral haemorrhage: a need for more data and new research directions. Lancet Neurol (2010) 1.07